Expression_NN
of_IN
the_DT
chemokine_NN
receptor_NN
BLR2\/EBI1_NN
is_VBZ
specifically_RB
transactivated_VBN
by_IN
Epstein-Barr_JJ
virus_NN
nuclear_JJ
antigen_NN
2_CD
._.

In_IN
our_PRP$
attempt_NN
to_TO
identify_VB
chemokine_NN
receptors_NNS
that_WDT
are_VBP
related_JJ
to_TO
Burkitt_NN
's_POS
lymphoma_NN
receptor_NN
1_CD
-LRB-_-LRB-
BLR1_NN
-RRB-_-RRB-
and_CC
are_VBP
expressed_VBN
in_IN
activated_VBN
lymphocytes_NNS
we_PRP
used_VBD
RT-PCR_NN
resulting_VBG
in_IN
the_DT
isolation_NN
of_IN
a_DT
cDNA_NN
encoding_VBG
a_DT
seven_CD
transmembrane_JJ
receptor_NN
termed_NN
BLR2_NN
._.

The_DT
protein_NN
shows_VBZ
significant_JJ
sequence_NN
similarities_NNS
to_TO
the_DT
family_NN
of_IN
G-protein_NN
coupled_JJ
chemokine_NN
receptors_NNS
and_CC
turned_VBD
out_RP
to_TO
be_VB
identical_JJ
to_TO
the_DT
recently_RB
described_VBN
receptor_NN
EBI1_NN
._.

Northern_NN
blot_NN
analysis_NN
revealed_VBD
that_IN
BLR2_NN
mRNA_NN
could_MD
be_VB
highly_RB
stimulated_VBN
in_IN
mitogen_NN
-_:
and_CC
anti-CD3-treated_JJ
peripheral_JJ
blood_NN
lymphocytes_NNS
._.

BLR2-specific_JJ
mRNA_NN
could_MD
be_VB
detected_VBN
in_IN
all_DT
Epstein-Barr_JJ
virus_NN
positive_JJ
B_NN
cell_NN
lines_NNS
._.

We_PRP
show_VBP
that_IN
transcription_NN
of_IN
the_DT
BLR2_NN
gene_NN
could_MD
be_VB
specifically_RB
induced_VBN
in_IN
Epstein-Barr_JJ
virus_NN
negative_JJ
BL_NN
41_CD
cells_NNS
via_IN
estrogen-mediated_JJ
activation_NN
of_IN
Epstein-Barr_JJ
virus_NN
nuclear_JJ
antigen_NN
2_CD
,_,
a_DT
key_JJ
regulator_NN
of_IN
viral_JJ
and_CC
cellular_JJ
genes_NNS
in_IN
immortalized_VBN
B_NN
cells_NNS
._.

Our_PRP$
data_NNS
suggest_VBP
an_DT
involvement_NN
of_IN
BLR2_NN
in_IN
the_DT
regulation_NN
of_IN
migration_NN
in_IN
activated_VBN
lymphocytes_NNS
and_CC
in_IN
viral_JJ
pathogenesis_NN
._.

